Salidroside's Anti-Tumor Effects in Ovarian Cancer
Author Information
Author(s): Yu Ge, Feng Xiaoling
Primary Institution: Harbin Medical University Cancer Hospital
Hypothesis
Does salidroside inhibit the malignant progression of ovarian cancer through the STAT3/c-Myc pathway?
Conclusion
Salidroside reduces ovarian cancer cell viability, migration, and invasiveness, induces apoptosis, and inhibits glycolysis by targeting the STAT3/c-Myc pathway.
Supporting Evidence
- Salidroside treatment significantly decreased the viability of ovarian cancer cells.
- Salidroside induced apoptosis in ovarian cancer cells.
- Salidroside inhibited the migration and invasion of ovarian cancer cells.
- Salidroside reduced glucose consumption and lactate production in ovarian cancer cells.
- Salidroside inhibited the STAT3/c-Myc signaling pathway.
Takeaway
Salidroside is a natural compound that helps fight ovarian cancer by making cancer cells less able to grow and spread.
Methodology
The study used various assays including CCK-8, flow cytometry, and western blotting to assess the effects of salidroside on ovarian cancer cells.
Limitations
The study primarily focused on in vitro and animal models, which may not fully represent human responses.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website